At the news
? BULLISHIMPACT 7/10 PRESS-RELEASE filed Apr 8, 2026 at 06:50 ET
ANI Pharmaceuticals announced FDA approval and immediate launch of Isosorbide Mononitrate Tablet USP, 10 mg and 20 mg, the generic version of Monoket®, reinforcing its generics pipeline and R&D execution. The product targets a limited-competition market, supporting near-term revenue diversification.
- FDA approved ANI's Abbreviated New Drug Application (ANDA) for Isosorbide Mononitrate Tablet USP, 10 mg and 20 mg.
- Product launched immediately as a generic version of Monoket®.
- Indication is for cardiovascular conditions, with limited competition expected.
- Strengthens ANI’s Generics business and R&D track record.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access